SB526 S Rules AM #1 3-24

Dellinger 7965

The Committee on Rules moved to amend the bill by striking out everything after the enacting clause and inserting in lieu thereof the following:

Article 5A. Pharmacist Prescribing authority act.

§30-5A-1. Short title.

This Act shall be known and may be cited as the Pharmacist Prescribing Authority Act.

§30-5A-2. Purpose.

The purpose of this Act is to authorize pharmacists to practice the full extent of their education and training to prescribe low-risk medications to patients.

§30-5A-3. Practice of pharmacy.

The scope of the practice of pharmacy includes all of §30-5-1 et seq. of this code, as well as the prescribing of drugs, drug categories, or devices, excluding controlled substances, that are prescribed in accordance with the product’s federal Food and Drug Administration-approved labeling and that are limited to conditions for which a relevant patient medication history has been taken and:

(1) Do not require a new diagnosis; or

(2) Have a test that is used to guide diagnosis or clinical decision-making that is waived under the federal Clinical Laboratory Improvement Amendments of 1988 that indicates the existence of a condition that is minor and generally self-limiting; or

(3) In the professional judgment of the pharmacist, are patient emergencies.

(4) The pharmacist may, within 72 hours, notify the patient’s primary care physician, if identified, of the test result and any permissible drug, drug categories, or devices that are prescribed.

§30-5A-4. Exemption from review requirements.

The addition of prescribing authority to the scope of the practice of pharmacy in West Virginia, as provided in §30-5A-3 of this code, is exempt from the requirements of §30-1A-1 et seq. of this code.

Adopted

Rejected